Related Experiment Video
Updated: Feb 8, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives
Andreas Tiefenbacher1, Robert Pirker1
1Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
Abstract:
Patients with advanced non-small cell lung cancer receive first-line therapy with chemotherapy, targeted therapies in case of tumors with driver mutations, and more recently also immune checkpoint inhibitors. Important controversies include the role of targeted therapies in combination with chemotherapy, optimal sequencing of treatments, treatment guidance by means of predictive biomarkers, and value-based judgements of treatments.
Insights
First-line advanced non-small cell lung cancer treatment involves chemotherapy, targeted therapies for specific mutations, and immune checkpoint inhibitors. Key debates focus on combining therapies, sequencing, biomarker use, and treatment value.
Area of Science:
- Oncology
- Medical Treatment
Background:
- Advanced non-small cell lung cancer (NSCLC) management has evolved with multiple therapeutic options.
- Current first-line strategies include chemotherapy, targeted therapies, and immune checkpoint inhibitors.
Purpose of the Study:
- To highlight key controversies and areas of ongoing research in first-line advanced NSCLC treatment.
- To discuss the complexities of integrating diverse therapeutic modalities.
Main Methods:
- Review of current treatment paradigms in advanced non-small cell lung cancer.
- Identification and discussion of major clinical and research controversies.
Main Results:
- Significant advancements in first-line therapy for advanced NSCLC.
- Identification of critical areas of debate including combination therapy, treatment sequencing, biomarker utility, and value-based assessments.
Conclusions:
- Optimizing first-line treatment for advanced NSCLC requires addressing current controversies.
- Further research is needed to guide the best use of chemotherapy, targeted therapies, and immune checkpoint inhibitors.
More Related Videos
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Treatment Resistant Cancers
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Lung Capacity
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality
Social Cognitive Perspective on Personality